Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: Study protocol for a randomized controlled trial

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Takeuchi, Satoru ^a   Mori, Kentaro ^a   Arimoto, Hirohiko ^b,c   Fujii, Kazuya ^a   Nagatani, Kimihiro ^a   Tomura, Satoshi ^a   Otani, Naoki ^a   Osada, Hideo ^a   Wada, Kojiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Japan Self Defense Forces Central Hospital   (Japan)

^c Mishuku Hospital   (Japan)

Author keywords

Cerebrospinal fluid; Delayed cerebral ischemia; Early brain injury; Hydrogen rich fluid; Magnesium; Oxidative stress; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

C REACTIVE PROTEIN; FASUDIL; GLUCOSE; HYDROGEN; HYDROGEN RICH INFUSION FLUID; INFUSION FLUID; MAGNESIUM ION; MAGNESIUM SULFATE; MALONALDEHYDE; NEURON SPECIFIC ENOLASE; PLACEBO; PROTEIN S100B; RINGER SOLUTION; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASOSPASM; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; GLASGOW COMA SCALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; NEUROIMAGING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION; CLINICAL TRIAL; COMPLICATION; INTRACRANIAL ANEURYSM; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PARENTERAL DRUG ADMINISTRATION;

ADULT; AGED; CLINICAL PROTOCOLS; HUMANS; HYDROGEN; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; INTRACRANIAL ANEURYSM; MAGNESIUM SULFATE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE;

EID: 84908146918     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-014-0176-1     Document Type: Article

References (50)

1. Bederson JB, Connolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994-1025. 10.1161/STROKEAHA.108.191395, 19164800.
2. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007, 369:306-318. 10.1016/S0140-6736(07)60153-6, 17258671.
3. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997, 28:660-664. 10.1161/01.STR.28.3.660, 9056628.
4. Shirao S, Yoneda H, Kunitsugu I, Ishihara H, Koizumi H, Suehiro E, Nomura S, Kato S, Fujisawa H, Suzuki M. Preoperative prediction of outcome in 283 poor-grade patients with subarachnoid hemorrhage: a project of the Chugoku-Shikoku Division of the Japan Neurosurgical Society. Cerebrovasc Dis 2010, 30:105-113. 10.1159/000314713, 20501995.
5. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010, 41:2391-2395. 10.1161/STROKEAHA.110.589275, 20798370.
6. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985, 16:562-572. 10.1161/01.STR.16.4.562, 3895589.
7. Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 2011, 76:446-454. 10.1016/j.wneu.2011.02.030, 22152574.
8. Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral vasospasm management. Neurosurg Focus 2006, 21:E8. 10.3171/foc.2006.21.3.8, 17029347.
9. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2010, 41:e47-52. 10.1161/STROKEAHA.109.556332, 19875741.
10. Golan E, Vasquez DN, Ferguson ND, Adhikari NK, Scales DC. Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis. J Crit Care 2013, 28:173-181. 10.1016/j.jcrc.2012.07.001, 23192249.
11. Wong GK, Boet R, Poon WS, Chan MT, Gin T, Ng SC, Zee BC. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011, 15:R52. 10.1186/cc10017, 21299874.
12. Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 2012, 380:44-49. 10.1016/S0140-6736(12)60724-7.
13. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002, 96:510-514. 10.3171/jns.2002.96.3.0510, 11883835.
14. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005, 36:1011-1015. 10.1161/01.STR.0000160801.96998.57, 15790946.
15. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010, 41:921-926. 10.1161/STROKEAHA.109.571125, 20378868.
16. Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 2006, 18:142-148. 10.1097/00008506-200604000-00009, 16628069.
17. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008, 69:33-39. 10.1016/j.surneu.2007.07.015, 18054611.
18. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med 2010, 38:1284-1290. 10.1097/CCM.0b013e3181f17878, 20228677.
19. Chang JJ, Mack WJ, Saver JL, Sanossian N. Magnesium: potential roles in neurovascular disease. Front Neurol 2014, 5:52. 10.3389/fneur.2014.00052, 24782823.
20. van Norden AG, van den Bergh WM, Rinkel GJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther 2005, 30:439-442. 10.1111/j.1365-2710.2005.00642.x, 16164489.
21. Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 2012, 97:14-37. 10.1016/j.pneurobio.2012.02.003, 22414893.
22. Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 2011, 43:27-40. 10.1007/s12035-010-8155-z, 21161614.
23. Mori K, Yamamoto T, Nakao Y, Osada H, Hara Y, Oyama K, Esaki T. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2009, 49:139-144. 10.2176/nmc.49.139.
24. Mori K, Yamamoto T, Miyazaki M, Hara Y, Aiko Y, Koike N, Sakamoto S, Nakao Y, Esaki T. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. J Neurosurg 2011, 114:1168-1175. 10.3171/2010.10.JNS10866, 21073257.
25. Takeuchi S, Wada K, Nagatani K, Otani N, Mori K. Magnesium for aneurysmal subarachnoid haemorrhage. Lancet 2012, 380:1381. 10.1016/S0140-6736(12)61791-7, 23084445.
26. Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008, 104:33-41. 10.1007/978-3-211-75718-5_7, 18456995.
27. Yuksel S, Tosun YB, Cahill J, Solaroglu I. Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis. Turk Neurosurg 2012, 22:529-533. 23015327.
28. Caner B, Hou J, Altay O, Fujii M, Zhang JH. Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. J Neurochem 2012, 123:12-21. 10.1111/j.1471-4159.2012.07939.x, 23050638.
29. Ostrowski RP, Tang J, Zhang JH. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke 2006, 37:1314-1318. 10.1161/01.STR.0000217310.88450.c3, 16556878.
30. Dixon BJ, Tang J, Zhang JH. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance. Med Gas Res 2013, 3:10. 10.1186/2045-9912-3-10, 23680032.
31. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007, 13:688-694. 10.1038/nm1577, 17486089.
32. Takeuchi S, Wada K, Nagatani K, Osada H, Otani N, Nawashiro H. Hydrogen may inhibit collagen-induced platelet aggregation: an ex vivo and in vivo study. Intern Med 2012, 51:1309-1313. 10.2169/internalmedicine.51.7161, 22687834.
33. Nagatani K, Nawashiro H, Takeuchi S, Tomura S, Otani N, Osada H, Wada K, Katoh H, Tsuzuki N, Mori K. Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies. Med Gas Res 2013, 3:13. 10.1186/2045-9912-3-13, 23799921.
34. Nagatani K, Wada K, Takeuchi S, Kobayashi H, Uozumi Y, Otani N, Fujita M, Tachibana S, Nawashiro H. Effect of hydrogen gas on the survival rate of mice following global cerebral ischemia. Shock 2012, 37:645-652. 10.1097/SHK.0b013e31824ed57c, 22392146.
35. Ishibashi T, Sato B, Rikitake M, Seo T, Kurokawa R, Hara Y, Naritomi Y, Hara H, Nagao T. Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Med Gas Res 2012, 2:27. 10.1186/2045-9912-2-27, 23031079.
36. Sun Q, Kawamura T, Masutani K, Peng X, Sun Q, Stolz DB, Pribis JP, Billiar TR, Sun X, Bermudez CA, Toyoda Y, Nakao A. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats. Cardiovasc Res 2012, 94:144-153. 10.1093/cvr/cvs024, 22287575.
37. Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, Zhang JH. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience 2010, 169:402-414. 10.1016/j.neuroscience.2010.04.043, 20423721.
38. Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res 2010, 44:971-982. 10.3109/10715762.2010.500328, 20815764.
39. Zhuang Z, Zhou ML, You WC, Zhu L, Ma CY, Sun XJ, Shi JX. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci 2012, 13:47. 10.1186/1471-2202-13-47, 22587664.
40. Hong Y, Guo S, Chen S, Sun C, Zhang J, Sun X. Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats. J Neurosci Res 2012, 90:1670-1680. 10.1002/jnr.22739, 22589232.
41. Zhuang Z, Sun XJ, Zhang X, Liu HD, You WC, Ma CY, Zhu L, Zhou ML, Shi JX. Nuclear factor-κB/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits. J Neurosci Res 2013, 91:1599-1608. 10.1002/jnr.23281, 24105634.
42. Hong Y, Shao A, Wang J, Chen S, Wu H, McBride DW, Wu Q, Sun X, Zhang J. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3β signaling pathway. PLoS One 2014, 9:e96212. 10.1371/journal.pone.0096212, 24763696.
43. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012, 43:1711-1737. 10.1161/STR.0b013e3182587839, 22556195.
44. Nakamura T, Matsui T, Hosono A, Okano A, Fujisawa N, Tsuchiya T, Indo M, Suzuki Y, Oya S, Chang HS. Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH. Acta Neurochir Suppl 2013, 115:81-85. 22890650.
45. Tachibana E, Harada T, Shibuya M, Saito K, Takayasu M, Suzuki Y, Yoshida J. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) 1999, 141:13-19. 10.1007/s007010050260.
46. Kaneda K, Fujita M, Yamashita S, Kaneko T, Kawamura Y, Izumi T, Tsuruta R, Kasaoka S, Maekawa T. Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients. Brain Res Bull 2010, 81:173-177. 10.1016/j.brainresbull.2009.10.020, 19887101.
47. Moritz S, Warnat J, Bele S, Graf BM, Woertgen C. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. J Neurosurg Anesthesiol 2010, 22:21-31. 10.1097/ANA.0b013e3181bdf50d, 20027011.
48. Fountas KN, Tasiou A, Kapsalaki EZ, Paterakis KN, Grigorian AA, Lee GP, Robinson JS. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus 2009, 26:E22. 10.3171/2009.2.FOCUS08311, 19409001.
49. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, Connolly ES, Mayer SA. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke 2009, 40:1963-1968. 10.1161/STROKEAHA.108.544700, 19359629.
50. Mori K, Yamamoto T, Miyazaki M, Hara Y, Koike N, Nakao Y. Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice. Neurol Med Chir (Tokyo) 2013, 53:596-600. 10.2176/nmc.oa2012-0295.